USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024
Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024
Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies
24-Jul-2020
North America
$4,950.00
Special Price $3,712.50 save 25 %
Description
With this research service, Frost & Sullivan’s Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, recombinant proteins, vaccines, and regenerative medicine. The forecast for the global biologics market till 2024 reveals interesting trend and paradigm shifts that are set to take place in the industry. Importantly, the study also identifies actionable growth opportunities for industry participants to profit upon.
This research service identifies the largest revenue-generating segments and key therapeutic areas for the global biologics industry. Accelerated regulatory approvals for biologic products and the emergence of next-generation technologies are highlighted, in addition to their influence on market trends during the forecast period. The study highlights the dynamics of the biologics industry and the sub-segments of the biologics market. Growth opportunities in antibody-drug conjugate (ADC), RNA therapy, and gene therapy platforms are also explored. Further, the study discusses the impact (such as the accelerated development of vaccines) of the COVID-19 pandemic on the biologics industry and the market. Current challenges facing the biologics industry such as the sluggish growth rate of vaccines, and recombinant proteins are discussed. Most importantly, this research service discusses possible future market trends such as the accelerated development of mRNA-based vaccines and the increasing importance of specialty bio-CDMOs for the development and commercialization of regenerative medicine. Based on the market trends and revenue forecasts, Frost & Sullivan’s group of analysts highlight key growth opportunities in ADC, RNA, and gene therapy platforms through successful drug launches such as Belantamab Malfodotin, Inclisiran, and Zolgensma.
Research Highlights
Highlights of the report include:
- Market revenue forecast for the global biologics market till 2024
- Segment-wise revenue forecast of the top market players and key therapeutic areas
- Top 3 predictions for the global biologics market
- Technology trends influencing the future outlook of the biologics market
- Growth opportunities in the global biologics market
- Strategic recommendations for the biologics market
- COVID-19 impact analysis on the biologics market
Key Issues Addressed
- What will be the revenue and growth rate for the global biologics market from 2020 to 2024?
- What will be the major segments influencing this revenue and growth rate?
- What are the key technologies and trends to watch for during the forecast period?
- What are the major growth opportunities in the biologics industry?
- What are the top predictions for the biologics market?
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Purpose of this Study
Methodology
5-step Process to Transformational Growth
Key Findings
Key Questions this Study will Answer
Market Engineering Measurements
Transformation in the Industry Ecosystem
Macro Trends—Biologics Discovery, Development and Manufacturing
Technology Trends—Biologics Discovery, Development and Manufacturing
5 Big Themes for the Global Biologics Market
Strategic Imperatives for the Biologics Market
Scope
Market Segmentation
Description of Main Product Categories
Characteristics of Biologics
Lifecycle of Biologics Products
Market Drivers and Restraints
Key Biologics Companies
Biologics R&D Expenditure
Regulatory Framework for Biologics Approval
Region-wise Regulatory Drug Approval Trends
Key Issues in Market Entry for Regenerative Medicine
Top-level Impact of COVID-19 Pandemic on the Biologics Market
Biologics Manufacturing and Supply Line Challenges
Biologics Pipeline Targeting COVID-19 (SARS-COV-2)
Revenue Forecast—COVID-19 Impact Methodology
Growth Opportunities Critical for Future Success in a Post-pandemic Biologics Market
Companies to Action
Strategic Imperatives for Companies in Light of COVID-19
Methodology
Market Engineering Measurements
Revenue Forecast—Pre-COVID-19 vs. Post-COVID-19 Impact
Product Segmentation
Total Biologics Market—Top 10 Products
Breakdown by Therapeutic Area
Changing Dynamics
Percent Revenue Forecast by Product Type
Antibody Therapies—Overview of Top 10 Products
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Anticipated Key Product Launches
Changing Dynamics
Technology Trends in the Antibody Therapy Platform
Recombinant Proteins—Overview of Top 10 Products
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Anticipated Key Product Launches
Changing Dynamics
Vaccines—Overview of Top 10 Products
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Anticipated Key Product Launches
Changing Dynamics
Cell & Gene Therapy—Overview of Top 10 Products
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Technology Trends in the Cell Therapy Platform
Anticipated Key Product Launches
Changing Dynamics
Technology Trends in RNA and Viral Vector Platforms
Roche AG
AMGEN
Sanofi
AbbVie
Novo Nordisk
Merck
Pfizer
Johnson & Johnson
Eli Lilly
GlaxoSmithKline
Major Growth Opportunities
Growth Opportunity 1—ADCs/Polyclonal Antibodies
The Future Trends in Antibody Therapy
ADC Pipeline Analysis
ADCs—Need for Outsourcing
Bio-CDMO Benchmarking—ADC Development and Manufacturing Services
Growth Opportunity 2—RNA-based Therapies & Vaccines
Strategic Imperatives for Better Vaccines
RNA Therapy Pipeline Analysis and Industry Partnerships
mRNA Technology set to Revolutionize Vaccine Therapies
Growth Opportunity 3—Gene Therapy Advancements
Investments & Partnerships Advancing CRISPR/Cas Gene Editing Technology
Gene Therapy—Collaborations and Partnerships
CDMOs to Drive the Growth of Gene Therapy
Growth Opportunity Matrix
Top 3 Predictions for the Market
Legal Disclaimer
Market Engineering Methodology
List of Key Companies Included in this Research Service
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
Popular Topics
Research Highlights
Highlights of the report include:
- Market revenue forecast for the global biologics market till 2024
- Segment-wise revenue forecast of the top market players and key therapeutic areas
- Top 3 predictions for the global biologics market
- Technology trends influencing the future outlook of the biologics market
- Growth opportunities in the global biologics market
- Strategic recommendations for the biologics market
- COVID-19 impact analysis on the biologics market
Key Issues Addressed
- What will be the revenue and growth rate for the global biologics market from 2020 to 2024?
- What will be the major segments influencing this revenue and growth rate?
- What are the key technologies and trends to watch for during the forecast period?
- What are the major growth opportunities in the biologics industry?
- What are the top predictions for the biologics market?
| No Index | No |
|---|---|
| Podcast | No |
| Author | Deepak Jayakumar |
| Industries | Healthcare |
| WIP Number | MEAA-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9571-B1,99C1-B1,9568-B1,9611-B1 |